Search by Drug Name or NDC

    NDC 25021-0791-20 LACOSAMIDE 10 mg/mL Details

    LACOSAMIDE 10 mg/mL

    LACOSAMIDE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is LACOSAMIDE.

    Product Information

    NDC 25021-0791
    Product ID 25021-791_67346497-1e9a-41be-9ff6-d5339ce16ab9
    Associated GPIs 72600036002020
    GCN Sequence Number 064437
    GCN Sequence Number Description lacosamide VIAL 200MG/20ML INTRAVEN
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 14344
    HICL Sequence Number 035872
    HICL Sequence Number Description LACOSAMIDE
    Brand/Generic Generic
    Proprietary Name LACOSAMIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name LACOSAMIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name LACOSAMIDE
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA214301
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0791-20 (25021079120)

    NDC Package Code 25021-791-20
    Billing NDC 25021079120
    Package 10 VIAL, GLASS in 1 CARTON (25021-791-20) / 20 mL in 1 VIAL, GLASS
    Marketing Start Date 2022-03-17
    NDC Exclude Flag N
    Pricing Information N/A